Mackenzie Financial’s Organon & Co OGN Stock Holding History

Mackenzie Financial’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-62,512	Closed	-$1.18M	–	1601
2024 Q1	$1.18M	Buy	+62,512	New	+$1.07M	﹤0.01%	847
2023 Q4	–	Sell	-13,148	Closed	-$214K	–	1559
2023 Q3	$214K	Buy	13,148 +932	+8%	+$19.4K	﹤0.01%	1254
2023 Q2	$251K	Buy	12,216 +646	+6%	+$14K	﹤0.01%	1238
2023 Q1	$272K	Sell	11,570 -145	-1%	-$3.89K	﹤0.01%	1222
2022 Q4	$327K	Sell	11,715 -744	-6%	-$19K	﹤0.01%	1068
2022 Q3	$292K	Buy	12,459 +5,493	+79%	+$166K	﹤0.01%	1101
2022 Q2	$235K	Sell	6,966 -59,225	-89%	-$2.07M	﹤0.01%	1212
2022 Q1	$2.31M	Sell	66,191 -21,200	-24%	-$725K	﹤0.01%	731
2021 Q4	$2.66M	Sell	87,391 -447,520	-84%	-$14.6M	﹤0.01%	711
2021 Q3	$17.5M	Buy	+534,911	New	+$17.1M	0.02%	374

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mackenzie Financial's OGN Position: Q2 2024 in Review

Mackenzie Financial sold out of Organon & Co (OGN) in Q2 2024, closing a stake of 62,512 shares — an estimated $1.18M sold.

Mackenzie Financial first reported a position in OGN in Q3 2021 and held it in 10 quarters. The position peaked at $17.5M in Q3 2021. 724 funds tracked by Wall St. Rank hold OGN as of Q2 2024.

Mackenzie Financial reported no remaining Organon & Co position as of Q2 2024 after selling out during the quarter.
Mackenzie Financial sold 62,512 Organon & Co shares in Q2 2024, an estimated $1.18M.
Mackenzie Financial first reported a position in Organon & Co in Q3 2021 and held it in 10 quarters.
Mackenzie Financial's Organon & Co position peaked at $17.5M in Q3 2021.
724 funds tracked by Wall St. Rank held Organon & Co as of Q2 2024.

Based on Mackenzie Financial's 13F filing for Q2 2024, filed 14 Aug 2024.